2006 Midyear Clinical Meeting
Click here to go to the previous page
Advanced Topics in Oncology Pharmacy Practice, Part I
Track:
Sessions
Program Code: 097-L01PART1
Date: Tuesday, December 5, 2006
Time: 8:00 AM to 11:00 AM
Location:
303C-D (CC)
MODERATOR:
Amy W. Valley, Pharm.D., BCOP, Vice President, Clinical Solutions, Pharmacy Healthcare Solutions, Grapevine, TX
SPEAKER(S):
Val R. Adams, Pharm.D., BCOP, Associate Professor, University of Kentucky College of Pharmacy, Lexington, Associate Professor, College of Pharmacy, University of Kentucky
Lung Cancer: Reasons for Optimism
Lisa E. Davis, Pharm.D., BCOP, Associate Professor, Clinical Pharmacy, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, PA
Colon Cancer
Amy J. Hatfield, Pharm.D., BCOP, Clinical Specialist, Hematologic Malignancies, The Johns Hopkins Hospital, Baltimore, MD
Ten Significant Developments in the Treatment of Leukemia
Description
Learning Objectives:
Describe the screening and current standard therapy for non-small cell lung cancer. Identify state of the art practices in the pharmacologic management of resectable and metastatic colon cancer. List ten significant developments in the treatment of patients with leukemia.